Sun Pharmaceutical Industries Ltd. is a prominent player in the Indian pharmaceutical industry. The company’s product portfolio is diverse, with a focus on generic and over-the-counter (OTC) medicines, which account for approximately 94% of its net sales. These medicines are used to treat a range of diseases, including cardiologic, psychiatric, neurological, gastroenterological, diabetic, and respiratory disorders. The remaining 6% of net sales come from the sale of active pharmaceutical ingredients (APIs), which are the primary components used in the production of medications.
As of March 2021, Sun Pharmaceutical Industries Ltd. had a significant global presence, with 44 production plants located around the world. This extensive manufacturing network enables the company to produce a large volume of pharmaceutical products, which are then distributed to various markets worldwide.
In terms of geographical distribution, the company’s net sales are divided among several key regions. India, the company’s home market, accounts for approximately 33% of net sales. The United States is another significant market, contributing around 31.3% of net sales. The remaining 35.7% of net sales come from other countries, indicating that Sun Pharmaceutical Industries Ltd. has a diversified global presence.
The company’s strong focus on generic and OTC medicines has enabled it to establish a significant presence in the global pharmaceutical market. Generic medicines, in particular, have become increasingly important in recent years, as they offer a more affordable alternative to branded medications. Sun Pharmaceutical Industries Ltd.’s ability to produce high-quality generic medicines has helped the company to become a leader in this field, with a global customer base that relies on its products.
Overall, Sun Pharmaceutical Industries Ltd. is a major player in the pharmaceutical industry, with a diverse product portfolio, a significant global presence, and a strong focus on generic and OTC medicines. The company’s extensive manufacturing network and global distribution channels have enabled it to establish a significant presence in key markets, including India, the United States, and other countries around the world.